Stimuli-responsive nano-assemblies for remotely controlled drug delivery. 2020

Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Stimuli-responsive nano-assemblies are emerging as promising drug delivery systems (DDSs) with spatial and temporal tenability, which can undergo structural transition for controlled drug release upon excitation by either exogenous or endogenous stimuli. Particularly, exogenous stimuli-responsive nano-assemblies based remotely controlled DDSs, have received much attention due to their accuracy and reliability realized by tunable exogenous triggers such as light, magnetic field, or temperature. In this review, we will briefly introduce the current state-of-the-art technologies of nano-assembly synthesis and summarize the recent advances in remotely controlled nano-assembly-based DDSs activated by different exogenous stimuli or endogenous/exogenous dual-stimuli. Furthermore, the pioneering progress in bio-cleanable stimuli-responsive nano-assemblies that holds great relevance to clinical translation will be described. Finally, we will conclude with our perspectives on current issues and future development of this field. The objective of this review is to outline current advances of nano-assemblies as remotely controlled DDSs, in hopes of accelerating the future development of intelligent nanomedicines.

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D053758 Nanoparticles Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging. Nanocrystalline Materials,Nanocrystals,Material, Nanocrystalline,Materials, Nanocrystalline,Nanocrystal,Nanocrystalline Material,Nanoparticle

Related Publications

Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
September 2021, Chemical communications (Cambridge, England),
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
October 2016, Advanced drug delivery reviews,
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
September 2020, Journal of materials chemistry. B,
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
November 2014, Chemical communications (Cambridge, England),
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
May 2024, Advanced healthcare materials,
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
September 2017, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology,
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
November 2013, Nature materials,
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
February 2022, Pharmaceutics,
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
January 2022, Frontiers in bioengineering and biotechnology,
Fangyuan Li, and Yu Qin, and Jiyoung Lee, and Hongwei Liao, and Nan Wang, and Thomas P Davis, and Ruirui Qiao, and Daishun Ling
February 2022, Advanced science (Weinheim, Baden-Wurttemberg, Germany),
Copied contents to your clipboard!